Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed May 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$102K
Net Open-Market Flow
-$102K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 7, 2026Sell(S)226$152.45$34K440
May 7, 2026Sell(S)428$153.56$66K12
May 7, 2026Sell(S)3$154.61$4649
May 7, 2026Sell(S)9$155.25$1K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-214820) within minutes of acceptance. Every field above traces to the original document. Verify it directly: